Similarly, SH3BGRL2 inhibits ccRCC proliferation and metastasis by activating the LATS1/2-YAP-TEAD1 signaling pathway, and TEAD1 promotes EMT through TWIST1 upregulation (Yin et al., 2020). This evidence concerns the gene TEAD1 and nonpapillary renal cell carcinoma.